Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan's National Claims Database. [PDF]
Maruyama H +5 more
europepmc +1 more source
Preliminary analysis of combined romosozumab and denosumab versus teriparatide and denosumab on bone mineral density. [PDF]
Chiang MH +9 more
europepmc +1 more source
Pre-Operative Bone Health in Elective Spine Surgery, From Risk Assessment to Optimization Strategies: A Narrative Review. [PDF]
Ng MK +11 more
europepmc +1 more source
From the Editor-in-Chief: Featured Articles in the December 2025 Issue. [PDF]
Han I.
europepmc +1 more source
Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review. [PDF]
Abdalbary M +4 more
europepmc +1 more source
Predictors of clinically meaningful bone mineral density gains with romosozumab: An explainable machine leaning analysis of a real-world cohort. [PDF]
Corredor DC, Pascual LÁC.
europepmc +1 more source
Romosozumab-Induced Epidural Calcification in a Hemodialysis Patient. [PDF]
Yoshikawa S.
europepmc +1 more source
The use of romosozumab versus denosumab in patients with osteoporosis. [PDF]
Floriano I, Silvinato A, Bernardo WM.
europepmc +1 more source
Bone Optimization for Perioperative Spine Patients: A Multidisciplinary Approach at a Single Academic Center. [PDF]
Suarez-Nieto MV +6 more
europepmc +1 more source
ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study. [PDF]
Adami G +12 more
europepmc +1 more source

